Status:
COMPLETED
Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Vaccines, Pneumococcal
Infant
Eligibility:
All Genders
56-112 years
Phase:
PHASE4
Brief Summary
The purpose of the study is to determine whether prophylactic antipyretic treatment after vaccination with Prevenar and a concomitant hexavalent DTPa combination vaccine reduces the rate of febrile re...
Eligibility Criteria
Inclusion
- Healthy infants age 55 to 112 days
- Subject's parents/legal guardians provide written informed consent
Exclusion
- Prematurely born subjects \< 37 weeks gestation
- Known or suspected disease of immune system
- Known or suspected hypersensitivity to any vaccine or vaccine component
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00294294
Start Date
May 1 2005
End Date
December 1 2006
Last Update
February 21 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.